Next Financial Group’s XBiotech XBIT Stock Holding History

Next Financial Group’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300	Closed	-$5K	–	2729
2021 Q1	$5K	Hold	300	–	–	﹤0.01%	2125
2020 Q4	$5K	Hold	300	–	–	﹤0.01%	2008
2020 Q3	$6K	Buy	+300	New	+$5.18K	﹤0.01%	1804

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

Next Financial Group's XBIT Position: Q2 2021 in Review

Next Financial Group sold out of XBiotech (XBIT) in Q2 2021, closing a stake of 300 shares — an estimated $5K sold.

Next Financial Group first reported a position in XBIT in Q3 2020 and held it in 3 quarters. The position peaked at $6K in Q3 2020. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2021.

Next Financial Group reported no remaining XBiotech position as of Q2 2021 after selling out during the quarter.
Next Financial Group sold 300 XBiotech shares in Q2 2021, an estimated $5K.
Next Financial Group first reported a position in XBiotech in Q3 2020 and held it in 3 quarters.
Next Financial Group's XBiotech position peaked at $6K in Q3 2020.
56 funds tracked by Wall St. Rank held XBiotech as of Q2 2021.

Based on Next Financial Group's 13F filing for Q2 2021, filed 13 Jul 2021.